| ESIGNATED FUNDS A list ofdesignate | ESIGNATED FUNDS A list ofdesignate | ESIGNATED FUNDS A list ofdesignate | d funds held during 2022— |
d funds held during 2022— |
2023 |
|---|---|---|---|---|---|
| Women's General Purpose |
Community midwifery |
||||
| Fundraising | Miscarriage Fund |
||||
| Kings Fund | Medical Education | Fund | |||
| Bereavement/Honeysuckle | MRCOG | ||||
| Arts for Health | Cancer Research | Fund | |||
| Anaesthetic | Fund | Staff Welfare Fund | |||
| Reproductive | Medicine | Unit Fund | Liverpool Fetal Fund | ||
| Gynae Oncology Nurses | Fund | Neonatal | |||
| Twin Birth | Training and Development |
||||
| Maternity | Assisted Conception | Fund | |||
| Cytogenetics Fund |
| Unrestricted | Restricted | Total | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Funds | Funds | Funds | Funds | ||||||
| Note | 2023 | 2023 | 2023 | 2022 | |||||
| 6000 | 6000 | 6000 | 6000 | ||||||
| Incoming resources: | |||||||||
| Income and endowments | from: | ||||||||
| Donations and legacies |
290 | 290 | 226 | ||||||
| Other trading activities |
53 | 53 | 33 | ||||||
| Investments | 13 | 21 | 21 | 20 | |||||
| Other income | 0 | 0 | 0 | ||||||
| Total incoming resources | 364 | 364 | 279 | ||||||
| Resources expended: | |||||||||
| Expenditure on: |
|||||||||
| Raising funds | 184 | 184 | 124 | ||||||
| Charitable activities |
224 | 224 | 112 | ||||||
| Total resources expended | 408 | 0 | 408 | 236 | |||||
| Net expenditure before investment gains/(losses) |
(44) | 0 | (44) | 43 | |||||
| Net (loss) / gain on investments | -unrealised | 12 | (90) | 0 | (90) | (52) | |||
| Net gains on investments | —realised | 10 | 0 | 10 | 67 | ||||
| Net (expenditure)/income | (124) | 0 | (124) | 58 | |||||
| Net movement in funds |
(124) | 0 | (124) | 58 | |||||
| Reconcigation ofFunds: |
|||||||||
| Fund balances brought |
forward | 1a April | 562 | 0 | 562 | 504 | |||
| Fund balances carried | forward | 31n March | 438 | 438 | 562 |
| Balance | Sheet as | at 31st March 2023 | ||||
|---|---|---|---|---|---|---|
| Unrestricted Funds |
Total Funds | Total Funds | ||||
| Note | 2023 | 2023 | 2022 | |||
| 6000 | 6000 | 9000 | ||||
| Fixed assets: | ||||||
| Investments | 12 | 814 | 814 | 912 | ||
| Total fixed assets | 814 | 814 | 912 | |||
| Current assets: | ||||||
| Debtors | 14 | |||||
| Cash at bank | and in hand |
15 | ||||
| Total current | assets | 14 | 14 | |||
| Liabilities: | ||||||
| Creditors and |
commitments | falling due within one year | 16 | (248) | (248) | «36) |
| Creditors and |
commitments | due greater than one year | «42) | 142 | 225 | |
| Total current | liabilities | (390) | 390 | 361) | ||
| Net current assets/(liabilities) | (376) | (376) | (350) | |||
| Total assets | less current | liabilities | 438 | 438 | 562 | |
| The funds of | the charity: | |||||
| Unrestricted funds |
17 | 436 | 438 | 562 | ||
| Total charity | funds | 438 | 438 | 562 |
| Statem | ent ofCash | Flo | ws | for | th | e year ended | 31st March 2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Total | Total | ||||||||
| Funds | Funds | ||||||||
| Note | 2023 | 2022 | |||||||
| f000 | 8000 | ||||||||
| Cash flows from operating | activities: | ||||||||
| Net cash | provided by operating |
activities | 18 | (115) | (25) | ||||
| Cash flows from investing | activities: | ||||||||
| Dividends | and interest from | investments | 21 | 20 | |||||
| Proceeds | from sale of investments | 371 | 194 | ||||||
| Purchase | of investments | 12 | (283) | (174) | |||||
| Net cash | provided by/(used |
in) | Investing | activities | 109 | 40 | |||
| Change in |
cash and cash equivalents | in | |||||||
| the reporting period |
(8) | 15 | |||||||
| Cash and | cash equivalents | at the beginning | of | ||||||
| the reporting period |
28 | 13 | |||||||
| Total cash and cash equivalents | at the end | of | |||||||
| the reporting period |
19 | 22 | 28 |
| Notes to the accounts | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Accounting Pogcies |
||||||||||
| 1.1.Legal Status | ||||||||||
| The Liverpool Women's NHS Foundation Charitable Trust |
is an unincorporated charity registered with the charity commission. |
The | address | is | ||||||
| Crown Street, Liverpool, LS7SS. |
||||||||||
| 1.2.Basta ofpreparation | ||||||||||
| The financial statements have been prepared under the historic cost convention, with the exception of |
investments which |
are | included | at | fair | |||||
| value. The financial statements have been prepared in accordance with the Statement of Recommended |
Practice: Accounting | and | Reporting | |||||||
| by Charities prepariing their accounts in accordance with (FRS102)issued on July 2014, and the Financial Reporting |
the Financial Reporting Standard applicable in the UK and Republic of Ireland Standard applicable in the United Kingdom and Republic of Ireland (FRS102) and |
|||||||||
| the Charities Act 201I and UK Generally Accepted Practice | as it applies from 1 January 2019. |
|||||||||
| The Trustee considers that there are no material uncertainties about the Chai'ity's ability to continue as a |
going concern. There | are no material | ||||||||
| uncertainties affecting the current years accounts. The Charity has recently reviewed its Investment |
policy thoroughly | with | its Investment | |||||||
| advisors Investec Wealth and Management and will continue to monitor and react accordingly to the changes in the financial was a net decrease in the closing fund balance in 2022/23 off124 from f562k at 1stApril 2022 to 2438k st 31st March 2023. |
markets. | There | ||||||||
| The Charity constitutes a public benefit entity as defined by FRS 102.The financial statements are prepared in sterling which |
is | the functional | ||||||||
| currency ofthe entity. | ||||||||||
| 1.3.Funds structure | ||||||||||
| Unrestricted funds comprise those funds which the Trustee is free to use for any purpose in furtherance |
of the charitable | objects. | Restriicted | |||||||
| funds comprise those funds where the donor has provided | for the donation to be spent in furlherance of |
a specified charitable | purpose. | |||||||
| The funds held are disclosed in note 17. |
||||||||||
| 1.4.Incoming resources | ||||||||||
| Ag incoming resources are recognised ance the Charity has entitlement to the resources, it is probable that the resources |
will | be received and | ||||||||
| the monetary value of incoming resources can be measured |
with sufficient reliability |
|||||||||
| Where there are terms or conditions attached to incoming |
resources, particularly grants, then these terms or conditions |
must | be | met | before | |||||
| the income is recognised as the entitlement condition will |
not be satisfied until that point. Where terms or conditions have |
not been | met | or | ||||||
| uncertainty exists as to whether they can be met then the relevant income is not recognised in the |
year but deferred | and | shown | on | the | |||||
| balance sheet as deferred income. |
||||||||||
| 1.5.Incoming resources from legacies |
||||||||||
| Legacies are accounted for as incoming resources either |
upon receipt or where the receipt of the legacy is probable. |
Receipt is probable | ||||||||
| when: | ||||||||||
| Confirmation has been received from the representatives |
ofthe estate that probate has been granted | |||||||||
| The executors have established that there are sufficient |
assets in the estate to pay the legacy, and | |||||||||
| All conditions attached to the legacy have been fulfilled |
orare within the charity's control |
|||||||||
| Ifthere is uncertainty as to the amount of the legacy and it |
cannot be reliably estimated then the legacy |
is shown as a contingent | asset | until | ag | |||||
| ofthe conditions for income recognition are met. |
||||||||||
| 1.6.Resources expended and irrecoverable VAT |
||||||||||
| Ag expenditure ls accounted for on an sccruals basis and has been classified under headings that aggregate ag costs relating |
to | each category | ||||||||
| ofexpense shown in the Statement of Financial Activities |
Expenditure is recognised when the following |
criteria are met: | ||||||||
| There is a present legal or constructive obligation resulting from a past event |
||||||||||
| It is more likely than not that a transfer ofbenefits (usuagy a cash benefit) will be required in settlement |
||||||||||
| The amount ofthe obligation can be measured or estimated reliably |
| Fund | Purpose | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| The Women's | Hospital | General | Purpose | Fund | Any chantable purpose(s) relating to the NHS wholly Hospital |
or mainly | for the | Liverpool | Women' s | ||||
| Liverpool Women's | Cancer | Charity | To further the advancement of scientific and medical related to cancer research. |
education | and | research | into topics | ||||||
| Community Midwifery |
Promoting the efficient performance of their duties by TrusL |
the midwives of the NHS |
Foundation | ||||||||||
| Reproductive | Medicine | Fund | To further tha advancement of scientific and medical related to infertility, miscarriage and menopause. |
education | and | research | into topics | ||||||
| Medical Education | Fund | To further the advancement of scientific and medical related to the field ofobstetdics and gynaecology. |
education | and | research | into topics | |||||||
| Fetal Centre | Research | and | Development | The investigation into causes ofsickness in the unborn cure and defeat ofthis sickness. |
child and | the prevention, | treatment, | ||||||
| The investigation into the causes of sickness in the |
newborn | child | and the |
prevention, | |||||||||
| NeonatalFund | treatment, cure and defeat of this sickness and to further the cause of premature newborn babies at the NHS Foundation Trust and to further the advancement of scientific and |
||||||||||||
| medical education and research into topics related to sickness in |
the newborn child. |
||||||||||||
| Other Funds: | |||||||||||||
| Women's Hospital |
Staff | Welfare | Fund | For the relief ofsickness by promoting the efficient performance oftheir the Liverpool Women's Hospital. |
duties by | the staff of | |||||||
| To further the advancement of scientific and medical |
education | and | research | into topics | |||||||||
| Training and |
Development | Fund | relating to pregnancy and problems associated with giving |
birth | and gynaecological |
||||||||
| problems. | |||||||||||||
| Women's Assisted | Conception | Fund | To further the advancement ofscientific and medical education into topics related in women. |
to infertility | |||||||||
| Cytogenetics | Fund | To further the advancement of scientific and medical related to cytogenetics |
education | and | research | into topics |
| 4.Analysis ofInco | me | ||||||
|---|---|---|---|---|---|---|---|
| 2023 | 2023 | 2023 | 2022 | ||||
| Unrestricted | Restdicted | Total | Total | ||||
| Funds | Funds | Funds | Funds | ||||
| 6000 | 6000 | 6000 | 6000 | ||||
| Donations and legacies; |
|||||||
| Donations and gifts |
285 | 285 | 204 | ||||
| Legacies | 5 | 5 | 22 | ||||
| Total donations and legacies |
290 | 0 | 290 | 226 | |||
| Other trading activities: |
|||||||
| Stall income | 34 | 34 | 25 | ||||
| Fundraising events |
19 | 19 | 8 | ||||
| Total other trading | activities | 53 | 53 | 33 | |||
| Income from investments: | |||||||
| Dividend income |
21 | 21 | 20 | ||||
| Total income from | investments | 21 | 0 | 21 | 20 | ||
| Other income: | |||||||
| Total other income | 0 | 0 | |||||
| Total Income | 364 | 0 | 364 | 279 | |||
| AO income in the current and |
prior year was unresiricted. | ||||||
| 5.Donated Goods | |||||||
| 2023 | 2023 | 2023 | 2022 | ||||
| Unrestricted | Restricted | Total | Total | ||||
| Funds | Funds | Funds | Funds | ||||
| 6000 | 6000 | f000 | 6000 | ||||
| Included within other trading |
activities: | ||||||
| Sale ofdonated items |
34 | 34 | 25 | ||||
| Total stall income | included | within other | |||||
| trading activities |
34 | 34 | 25 |
| 7.1 Support 8 Governance | 7.1 Support 8 Governance | Costs | Costs | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2023 | 2023 | 2022 | ||||||
| Unrestricted | Restricted | Total | Total | ||||||
| Funds | Funds | Funds | Funds | ||||||
| 5000 | 8000 | 6000 | 5000 | ||||||
| Support Women's |
Costs: Financial Services NHS Foundation Trust |
provided | by | Liverpool | 19 | 19 | 19 | ||
| Governance Costs: Independent | Examination | Fees | |||||||
| Total | 21 | 0 | 21 | 21 |
| 7.2 Apportionment | 7.2 Apportionment | ofSupport &Governance | ofSupport &Governance | ofSupport &Governance | ofSupport &Governance | ofSupport &Governance | ofSupport &Governance | Costs across Charitable | Activities | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 2023 | 2023 | 2023 | 2022 | ||||||||||
| Patient welfare | Staffwelfare | Equipment and Research |
Total | Total | ||||||||||
| FOOO | 6000 | 5000 | 5000 | 5000 | ||||||||||
| Support Costs: Financial Liverpool Women's NHS |
Services provided Foundation Trust |
by | 10 | 19 | 19 | |||||||||
| Governance | Costs: Independent | Examination | ||||||||||||
| Fees | ||||||||||||||
| Total | 10 | 21 | 21 | |||||||||||
| 7.3Analysis | ofexpenditure | |||||||||||||
| 2023 | 2023 | 2023 | 2023 | 2022 | ||||||||||
| Unrestricted | Unrestricted | Restricted | Total | Total | ||||||||||
| Funds | Funds | Funds | ||||||||||||
| Support | & | |||||||||||||
| Governance | ||||||||||||||
| Costs | ||||||||||||||
| 6000 | f000 | 8000 | f000 | 6000 | ||||||||||
| Expenditure | on raising | funds: | ||||||||||||
| Staging fundraising | events | 56 | 56 | 13 | ||||||||||
| Fundraising | team | costs | 120 | 120 | 102 | |||||||||
| Investment | management | costs | 8 | 8 | 9 | |||||||||
| Total expenditure | on raising funds | 184 | 184 | 124 | ||||||||||
| Expenditure | on charitable | activities: | ||||||||||||
| Patient welfare | 90 | 11 | 101 | 66 | ||||||||||
| Staff welfare | 94 | 9 | 103 | 45 | ||||||||||
| Equipment | 20 | 0 | 20 | 1 | ||||||||||
| Research | 0 | 0 | 0 | 0 | ||||||||||
| Total expenditure | on charitable | activities | 204 | 20 | 0 | 224 | 112 | |||||||
| Total Expenditure | 388 | 20 | 0 | 408 | 236 |
| 8.Independent examination |
8.Independent examination |
and audit fees |
|---|---|---|
| Fees for examination | ofthe | accounts: |
| Independent examiner's |
fees | |
| Total fees |
| Please refer to the Trustee's Annual |
Please refer to the Trustee's Annual |
report to the Account for additional | information | on the grant making | activities performed | duding | the year to |
|---|---|---|---|---|---|---|---|
| 31stMarch 2023. | |||||||
| 11.Transfers between funds | |||||||
| There were no transfers between |
funds during 2022/23 (2021/22:fnil). | ||||||
| 12.Fixed asset investments | |||||||
| 2023 | 2022 | ||||||
| Movement in fixed asset investment |
Total | Total | |||||
| f000 | 8000 | ||||||
| Market Value brought forward |
892 | 897 | |||||
| Add: additions to investment at cost |
283 | 174 | |||||
| Less: disposals at carrying value |
(282) | (127) | |||||
| Add: net (loss) / gain on revaluation | -unrealised | (90) | (52) | ||||
| Market Value as at 31 March | 803 | 892 | |||||
| Cash held as part of investment | ponfolio | 20 | |||||
| Total investment value as at 31 March |
814 | 912 | |||||
| Historic Cost as at 31 March | 729 | 708 |
| 2023 | 2022 | |||||
|---|---|---|---|---|---|---|
| Fixed asset Investments | by type | Total | Total | |||
| 8000 | f000 | |||||
| Investments lisled |
on a recognised | Stock | ||||
| Exchange: | ||||||
| UK Equities | 183 | 315 | ||||
| European equities |
64 | 37 | ||||
| North Amedican | equities | 184 | 201 | |||
| Japanese equities |
14 | 15 | ||||
| Fsr East and Australasian | equities | 16 | 26 | |||
| Emerging economies |
33 | 18 | ||||
| International equities |
29 | 14 | ||||
| Properly | 43 | 50 | ||||
| Alternative Assets |
72 | 70 | ||||
| Other investments: | ||||||
| UK fixed interest | 92 | 123 | ||||
| Overseas Fixed |
Interest | 73 | 23 | |||
| Cash held as part | ofthe investment | portfolio | 11 | 20 | ||
| Total fixed asset | investments | 814 | 912 | |||
| 13.Total gross income from investments | and cash on deposit | |||||
| 2023 | 2022 | |||||
| Total | Total | |||||
| 6000 | FOOO | |||||
| Investments lisled |
on a recognised | Stock Exchange: | ||||
| UK Equities | 11 | 14 | ||||
| European equities |
3 | 0 | ||||
| Overseas and emerging |
equities | 2 | 3 | |||
| Other investments: | ||||||
| UK fixed interest | ||||||
| UK Property | ||||||
| Alternative Assets |
||||||
| Total | 21 | 20 |
| 2023 | 2022 | |||
|---|---|---|---|---|
| Total | Total | |||
| 6000 | 6000 | |||
| Debtors under one year | ||||
| Investment income |
receivable | |||
| Total | ||||
| 15.Analysis ofcash | and deposits | |||
| 2023 | 2022 | |||
| Total | Total | |||
| 6000 | 6000 | |||
| Shorl term investments | and deposits | 1 | ||
| Cash at bank and | in hand | 10 | ||
| Total |
| 16.Analy | s | is of liabilities | end com | mitments | ||
|---|---|---|---|---|---|---|
| 2023 | 2022 | |||||
| Total | Total | |||||
| 8000 | 5000 | |||||
| Creditors | &commitments | under | one year | |||
| Amounts | due to Liverpool | Women's | NHS | |||
| Foundation | Trust | 47 | 96 | |||
| Commitments | 201 | 38 | ||||
| Other accruals | 0 | 2 | ||||
| Total | 248 | 136 | ||||
| 2023 | 2022 | |||||
| Total | Total | |||||
| 6000 | 8000 | |||||
| Creditors | &commitments | over one year | ||||
| Commitments | 142 | 225 | ||||
| Total | 142 | 225 |
| 2023 | 2022 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Total | ||||||||||||
| 8000 | 8000 | ||||||||||||
| Balance | at the start ofthe | reporting | period | 263 | 252 | ||||||||
| Amounts | added in current |
period | 275 | 95 | |||||||||
| Amounts | charged against | commitments | in the | current period | (194) | (84) | |||||||
| Unused | amounts reversed |
during | the period | (1) | 0 | ||||||||
| Balance | at the snd ofthe | reporting | period | 343 | 263 | ||||||||
| 17.Unrestricted funds |
|||||||||||||
| Funds brought | Incoming | Resources | Loss on | Funds carried | |||||||||
| Analysis ofunrestricted designated funds |
and material | forward at 01-Apr-22 |
resources | expended | investments | forward at 31-Mar-23 |
|||||||
| 8000 | f000 | 6000 | 6000 | FOOO | |||||||||
| General | Purpose | 200 | 228 | (208) | (40) | 180 | |||||||
| Liverpool | Women's Cancer Charity |
65 | 4 | (18) | (7) | 44 | |||||||
| Community Midwifery |
31 | 11 | (11) | (4) | 27 | ||||||||
| Reproductive Medicine |
Fund | 10 | 0 | (2) | (1) | 7 | |||||||
| Medical | Education | 42 | 0 | (10) | (4) | 28 | |||||||
| Fetal Centre Research | & | Development | Fund | 32 | 5 | (16) | (3) | 18 | |||||
| Neonatal | Fund | 155 | 81 | (114) | (17) | 105 | |||||||
| Other Funds | 27 | 35 | (29) | (4) | 29 | ||||||||
| Total | 562 | 364 | (408) | (80) | 438 |
| Funds brought | Incoming | Incoming | Resources | Gain on | Funds carried | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analysis ofunrestricted designated funds |
and material | forward at 01-Apr-21 |
resources | expended | investments | forward at 31-Mar-22 |
||||||||
| 6000 | 6000 | 6000 | 6000 | 6000 | ||||||||||
| General Purpose | 140 | 130 | (75) | 200 | ||||||||||
| Liverpool | Women's | Cancer Charity | 74 | 10 | (21) | 65 | ||||||||
| Community Midwifery |
34 | 7 | (11) | 31 | ||||||||||
| Reproductive Medicine Fund |
2 | 3 | 5 | 10 | ||||||||||
| Medical Education | 51 | 2 | (12) | 42 | ||||||||||
| Fetal Centre Research | & | Development | Fund | 50 | 7 | (26) | 32 | |||||||
| Neonatal | Fund | 122 | 97 | (68) | 155 | |||||||||
| Other Funds | 31 | 23 | (28) | 27 | ||||||||||
| Total | 504 | 279 | (236) | 15 | 562 | |||||||||
| The purposes ofthe |
funds | are given | in | note 3. | ||||||||||
| 18.Reconciliation | ofnet | movement | in funds to net cash flow from | operating | activities | |||||||||
| 2023 | 2022 | |||||||||||||
| Total | Total | |||||||||||||
| 6000 | 6000 | |||||||||||||
| Net movement in funds |
(124) | 43 | ||||||||||||
| Adjustments for: |
||||||||||||||
| Dividends | and interest | on | investments | (20) | (20) | |||||||||
| (Increase) | / decrease | in | debtors | 0 | 1 | |||||||||
| Increase / |
(decrease) | in | creditors | 29 | (49) | |||||||||
| Total | (115) | (25) | ||||||||||||
| 19.Analysis ofcash | and | cash equivalents | ||||||||||||
| 2023 | 2022 | |||||||||||||
| Total | Total | |||||||||||||
| 6000 | 6000 | |||||||||||||
| Cash and | deposits: | |||||||||||||
| Short term | investments | and deposits | 10 | |||||||||||
| Cashin hand | 1 | |||||||||||||
| 21 | 8 | |||||||||||||
| Cash held | as part ofthe | investment | porffclic | 11 | 20 | |||||||||
| 22 | 28 | |||||||||||||
| 20.Net Debt | ||||||||||||||
| 2022/23: | At 1 April 2022 | Cashflows | At 31 March 2023 | |||||||||||
| 6000 | 6000 | 6000 | ||||||||||||
| Cash and | deposits | 28 | (6) | 22 | ||||||||||
| Loans due | within one | year | (96) | 49 | (47) | |||||||||
| Total | (68) | 43 | (25) | |||||||||||
| 2021/22: | At 1 April 2021 | Cashflows | At 31 March 2022 | |||||||||||
| 6000 | 6000 | 6000 | ||||||||||||
| Cash and | deposits | 13 | 15 | 28 | ||||||||||
| Loans due | within one | year | (156) | 60 | (96) | |||||||||
| Total | (143) | 75 | (68) |
| Unrestricted | Restricted | Total | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Note | Funds | Funds | Funds | Funds | |||||
| 2022 | 2022 | 2022 | 2021 | ||||||
| 6000 | 6000 | 5000 | 5000 | ||||||
| Incoming resources: | |||||||||
| Income and endowments | from: | ||||||||
| Donations and legacies |
226 | 226 | 328 | ||||||
| Other trading activities |
33 | 33 | 5 | ||||||
| Investments | 13 | 20 | 20 | 19 | |||||
| Other income | 0 | 0 | 0 | ||||||
| Total incoming resources |
279 | 279 | 352 | ||||||
| Resources expended; | |||||||||
| Expenditure on: |
|||||||||
| Raising funds | 124 | 124 | 118 | ||||||
| Charitable activities |
112 | 112 | 229 | ||||||
| Total resources expended | 236 | 236 | 347 | ||||||
| Net expenditure before |
investment | gains | 43 | 43 | |||||
| Net (loss) / gain on investments | —unrealised | 12 | (52) | (52) | 141 | ||||
| Net gains on investments | -realised | 67 | 67 | 19 | |||||
| Net (expenditure)/income | 58 | 58 | 165 | ||||||
| Net movement in funds |
58 | 58 | 165 | ||||||
| Reconciliation ofFunds; |
|||||||||
| Fund balances brought forward |
1e April | 504 | 504 | 339 | |||||
| Fund balances carried forward | 31e | March | 562 | 562 | 504 |